Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...
Nursing Times’ new, open access, learning unit will teach nurses when and how to report suspected adverse drug reactions ...
GlobalData on MSN18h
Valneva’s chikungunya vaccine wins UK approvalValneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...
GlobalData on MSN2d
MHRA seeks input on new regulatory guidance for cancer vaccinesThe proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
Hosted on MSN21h
Landmark Agreement Among Africa's Leading National Medicines Regulatory Authorities to Foster Collaboration [press release]The Africa Centres for Disease Control and Prevention (Africa CDC) and African Union Development Agency - New Partnership for Africa's Development (AUDA-NEPAD) are proud to announce the signing of a ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued new guidance on meeting UK medical devices ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...
The world’s first vaccine for mosquito-borne chikungunya virus has been approved by the UK’s Medicines and Healthcare ...
Packets of one antibiotic medication are being recalled from suppliers due to an extra tablet found in some batches.
Telegraph investigation finds ‘critical’ information missing from early warnings about AstraZeneca vaccine’s side effects ...
Batches of antibiotic medication are being recalled from suppliers after they were found to contain an extra tablet.
The MHRA has issued guidance to help manufacturers ensure that digital mental health technologies are effective, reliable and safe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback